PMC9981645_01
Timeline with relevant data from the episode of care, according to CARE case report guidelines. BM, bone marrow. MRD, minimal residual disease. BFM95, Berlin-Frankfurt-Munster (BFM)-ALL-95 regimen. CR, complete remission. PET-CT, Whole-body positron emission tomography scanning. HR, high risk; PDN, prednisone; VCR, vincristine; DNR, daunorubicin; ASP, E coli L-asparaginase; MTX, methotrexate; ARA-C, cytarabine; CPM, cyclophosphamide; VDS, vindesine; IFO, ifosfamide; DXM, dexamethasone; DOX, doxorubicin; HD, high dose; ID, intermediate dose; TIT, triple intrathecal therapy; VP-16, Etoposide.
fphar-14-1051305-g001.jpg
PMC9981645_01_fphar-14-1051305-g001.jpg
F1
The timeline with relevant data from the episode of care was demonstrated in Figure 1.